vlog

Object moved to here.

Inflammatory Biomarkers and Risk of Psychiatric Disorders | Psychiatry and Behavioral Health | JAMA Psychiatry | vlog

vlog

[Skip to Navigation]
Sign In
1.
GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137-150. doi:
2.
Gradus JL. Prevalence and prognosis of stress disorders: a review of the epidemiologic literature. Clin Epidemiol. 2017;9:251-260. doi:
3.
Arango C, Dragioti E, Solmi M, et al. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry. 2021;20(3):417-436. doi:
4.
Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2019;1437(1):57-67. doi:
5.
Miller AH. Beyond depression: the expanding role of inflammation in psychiatric disorders. World Psychiatry. 2020;19(1):108-109. doi:
6.
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. doi:
7.
Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011;130(2):226-238. doi:
8.
Passos IC, Vasconcelos-Moreno MP, Costa LG, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002-1012. doi:
9.
Peruzzolo TL, Pinto JV, Roza TH, et al. Inflammatory and oxidative stress markers in posttraumatic stress disorder: a systematic review and meta-analysis. Mol Psychiatry. 2022;27(8):3150-3163. doi:
10.
Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446-457. doi:
11.
Milaneschi Y, Kappelmann N, Ye Z, et al. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Mol Psychiatry. 2021;26(12):7393-7402. doi:
12.
Eraly SA, Nievergelt CM, Maihofer AX, et al; Marine Resiliency Study Team. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry. 2014;71(4):423-431. doi:
13.
Chu AL, Stochl J, Lewis G, Zammit S, Jones PB, Khandaker GM. Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort. Brain Behav Immun. 2019;76:74-81. doi:
14.
Sumner JA, Chen Q, Roberts AL, et al. Posttraumatic stress disorder onset and inflammatory and endothelial function biomarkers in women. Brain Behav Immun. 2018;69:203-209. doi:
15.
Ludvigsson JF, Appelros P, Askling J, et al. Adaptation of the Charlson Comorbidity Index for register-based research in Sweden. Clin Epidemiol. 2021;13:21-41. doi:
16.
Okada Y, Wu D, Trynka G, et al; RACI consortium; GARNET consortium. Genetics of rheumatoid arthritis contributes to biology and drug discovery. ٳܰ. 2014;506(7488):376-381. doi:
17.
Meier SM, Trontti K, Purves KL, et al. Genetic variants associated with anxiety and stress-related disorders: a genome-wide association study and mouse-model study. JAMA Psychiatry. 2019;76(9):924-932. doi:
18.
Astle WJ, Elding H, Jiang T, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. . 2016;167(5):1415-1429.e19. doi:
19.
Pietzner M, Wheeler E, Carrasco-Zanini J, et al. Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nat Commun. 2020;11(1):6397. doi:
20.
Mbatchou J, Barnard L, Backman J, et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet. 2021;53(7):1097-1103. doi:
21.
Said S, Pazoki R, Karhunen V, et al. Genetic analysis of over half a million people characterises C-reactive protein loci. Nat Commun. 2022;13(1):2198. doi:
22.
Funatogawa I, Funatogawa T. Longitudinal Data and Linear Mixed Effects Models. In: Funatogawa I, Funatogawa T, eds. Longitudinal Data Analysis: Autoregressive Linear Mixed Effects Models. Springer Singapore; 2018:1-26. doi:
23.
Bulik-Sullivan BK, Loh PR, Finucane HK, et al; Schizophrenia Working Group of the Psychiatric Genomics Consortium. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291-295. doi:
24.
Lu Q, Li B, Ou D, et al. A powerful approach to estimating annotation-stratified genetic covariance via GWAS summary statistics. Am J Hum Genet. 2017;101(6):939-964. doi:
25.
Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880-1906. doi:
26.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512-525. doi:
27.
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304-314. doi:
28.
Cheng Q, Zhang X, Chen LS, Liu J. Mendelian randomization accounting for complex correlated horizontal pleiotropy while elucidating shared genetic etiology. Nat Commun. 2022;13(1):6490. doi:
29.
Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081. doi:
30.
Rengasamy M, Moriarity D, Kraynak T, Tervo-Clemmens B, Price R. Exploring the multiverse: the impact of researchers’ analytic decisions on relationships between depression and inflammatory markers. ܰDZ⳦DZ󲹰DZDz. 2023;48(10):1465-1474. doi:
31.
Gialluisi A, Di Castelnuovo A, Bracone F, et al. Associations between systemic inflammation and somatic depressive symptoms: findings from the Moli-Sani study. Depress Anxiety. 2020;37(9):935-943. doi:
32.
Sealock JM, Lee YH, Moscati A, et al. Use of the PsycheMERGE Network to investigate the association between depression polygenic scores and white blood cell count. JAMA Psychiatry. 2021;78(12):1365-1374. doi:
33.
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-454. doi:
34.
Lux A, Aschermann S, Biburger M, Nimmerjahn F. The pro and anti-inflammatory activities of immunoglobulin G. Ann Rheum Dis. 2010;69(suppl 1):i92-i96. doi:
35.
Böhm S, Schwab I, Lux A, Nimmerjahn F. The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol. 2012;34(3):443-453. doi:
36.
Zeginiadou T, Kolias S, Kouretas D, Antonoglou O. Nonlinear binding of sex steroids to albumin and sex hormone binding globulin. Eur J Drug Metab Pharmacokinet. 1997;22(3):229-235. doi:
37.
Sikora M, Marczak Ł, Perła-Kajan J, Jakubowski H. Sex affects N-homocysteinylation at lysine residue 212 of albumin in mice. Sci Rep. 2019;9(1):2669. doi:
38.
de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. doi:
39.
Dentali F, Nigro O, Squizzato A, et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: a systematic review and meta-analysis of the literature. Int J Cardiol. 2018;266:31-37. doi:
40.
Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation. 2013;10:43. doi:
41.
Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther. 2021;27(1):36-47. doi:
42.
Aguilar-Valles A, Kim J, Jung S, Woodside B, Luheshi GN. Role of brain transmigrating neutrophils in depression-like behavior during systemic infection. Mol Psychiatry. 2014;19(5):599-606. doi:
43.
Kim YR, Kim YM, Lee J, Park J, Lee JE, Hyun YM. Neutrophils return to bloodstream through the brain blood vessel after crosstalk with microglia during LPS-induced neuroinflammation. Front Cell Dev Biol. 2020;8:613733. doi:
44.
Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry. 2007;62(11):1310-1316. doi:
45.
Huntoon KM, Wang Y, Eppolito CA, et al. The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol. 2008;84(1):170-181. doi:
46.
Zhang C, Wei C, Huang X, et al. MPC-n (IgG) improves long-term cognitive impairment in the mouse model of repetitive mild traumatic brain injury. BMC Med. 2023;21(1):199. doi:
Views 7,994
Original Investigation
August 21, 2024

Inflammatory Biomarkers and Risk of Psychiatric Disorders

Author Affiliations
  • 1Mental Health Center and West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China
  • 2Med-X Center for Informatics, Sichuan University, Chengdu, China
  • 3West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China
  • 4Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
  • 5Center of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavík, Iceland
  • 6Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
JAMA Psychiatry. 2024;81(11):1118-1129. doi:10.1001/jamapsychiatry.2024.2185
Key Points

Question Are inflammatory biomarkers associated with subsequent risk of psychiatric disorders?

Findings In this cohort study evaluating data of 585 279 individuals from the Swedish Apolipoprotein Mortality Risk (AMORIS) cohort and validated with the data of 485 620 individuals from the UK Biobank, inflammatory biomarkers including leukocytes, haptoglobin, C-reactive protein, and immunoglobulin G were associated with the risk of psychiatric disorders using cohort and nested case-control study analysis. Moreover, mendelian randomization analyses suggested a possible causal link between leukocytes and depression.

Meaning This study suggests a role of inflammation in the development of psychiatric disorders and may aid in identifying individuals at high risk.

Abstract

Importance Individuals with psychiatric disorders have been reported to have elevated levels of inflammatory biomarkers, and prospective evidence is limited regarding the association between inflammatory biomarkers and subsequent psychiatric disorders risk.

Objective To assess the associations between inflammation biomarkers and subsequent psychiatric disorders risk.

Design, Setting, and Participants This was a prospective cohort study including individuals from the Swedish Apolipoprotein Mortality Risk (AMORIS) cohort, with no prior psychiatric diagnoses and having a measurement of at least 1 inflammatory biomarker. Data from the UK Biobank were used for validation. Longitudinal trajectories of studied biomarkers were visualized before diagnosis of psychiatric disorders in the AMORIS cohort via a nested case-control study. In addition, genetic correlation and mendelian randomization (MR) analyses were conducted to determine the genetic overlap and causality of the studied associations using publicly available GWAS summary statistics.

Exposures Inflammatory biomarkers, eg, leukocytes, haptoglobin, immunoglobulin G (IgG), C-reactive protein (CRP), platelets, or albumin.

Main Outcomes and Measures Any psychiatric disorder or specific psychiatric disorder (ie, depression, anxiety, and stress-related disorders) was identified through the International Statistical Classification of Diseases, Eighth, Ninth, and Tenth Revision codes.

Results Among the 585 279 individuals (mean [SD] age, 45.5 [14.9] years; 306 784 male [52.4%]) in the AMORIS cohort, individuals with a higher than median level of leukocytes (hazard ratio [HR], 1.11; 95% CI, 1.09-1.14), haptoglobin (HR, 1.13; 95% CI, 1.12-1.14), or CRP (HR, 1.02; 95% CI, 1.00-1.04) had an elevated associated risk of any psychiatric disorders. In contrast, we found an inverse association for IgG level (HR, 0.92; 95% CI, 0.89-0.94). The estimates were comparable for depression, anxiety, and stress-related disorders, specifically, and these results were largely validated in the UK Biobank (n = 485 620). Analyses of trajectories revealed that individuals with psychiatric disorders had higher levels of leukocytes and haptoglobin and a lower level of IgG than their controls up to 30 years before the diagnosis. The MR analysis suggested a possible causal relationship between leukocytes and depression.

Conclusions and Relevance In this cohort study, inflammatory biomarkers including leukocytes, haptoglobin, CRP, and IgG were associated with a subsequent risk of psychiatric disorders, and thus might be used for high-risk population identification. The possible causal link between leukocytes and depression supports the crucial role of inflammation in the development of psychiatric disorders.

×